Allianz Asset Management Gmb H Mersana Therapeutics, Inc. Transaction History

Allianz Asset Management Gmb H

$69.7 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$4.0 - $7.02 $121,600 - $213,408	30,400 Added 50.58%	90,500 $371,000
Q3 2022 Nov 08, 2022	SELL	$4.63 - $8.0 $810,828 - $1.4 Million	-175,125 Reduced 74.45%	60,100 $406,000
Q2 2022 Aug 12, 2022	BUY	$2.84 - $5.0 $75,842 - $133,525	26,705 Added 12.81%	235,225 $1.09 Million
Q1 2022 May 13, 2022	SELL	$3.74 - $6.63 $246,271 - $436,572	-65,848 Reduced 24.0%	208,520 $831,000
Q4 2021 Feb 11, 2022	BUY	$5.48 - $9.86 $229,672 - $413,242	41,911 Added 18.03%	274,368 $1.71 Million
Q3 2021 Nov 10, 2021	SELL	$8.56 - $14.47 $436,500 - $737,868	-50,993 Reduced 17.99%	232,457 $2.19 Million
Q2 2021 Aug 16, 2021	BUY	$13.28 - $18.07 $19,481 - $26,508	1,467 Added 0.52%	283,450 $3.85 Million
Q1 2021 May 13, 2021	BUY	$15.31 - $26.52 $812,226 - $1.41 Million	53,052 Added 23.17%	281,983 $4.56 Million
Q4 2020 Feb 16, 2021	SELL	$16.84 - $27.59 $123,235 - $201,903	-7,318 Reduced 3.1%	228,931 $6.09 Million
Q3 2020 Nov 13, 2020	BUY	$16.2 - $25.7 $1.54 Million - $2.44 Million	95,034 Added 67.3%	236,249 $4.4 Million
Q2 2020 Aug 14, 2020	BUY	$5.24 - $23.4 $739,966 - $3.3 Million	141,215 New	141,215 $3.3 Million
Q3 2019 Nov 13, 2019	SELL	$1.54 - $4.2 $80,460 - $219,437	-52,247 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$3.84 - $6.4 $4,124 - $6,873	1,074 Added 2.1%	52,247 $212,000
Q1 2019 May 13, 2019	BUY	$3.51 - $7.3 $103,639 - $215,547	29,527 Added 136.41%	51,173 $269,000
Q4 2018 Feb 14, 2019	SELL	$3.45 - $9.72 $82,727 - $233,075	-23,979 Reduced 52.56%	21,646 $88,000
Q3 2018 Nov 13, 2018	SELL	$10.0 - $19.02 $200,000 - $380,400	-20,000 Reduced 30.48%	45,625 $456,000
Q1 2018 May 14, 2018	SELL	$13.56 - $18.48 $223,387 - $304,439	-16,474 Reduced 20.07%	65,625 $1.04 Million
Q3 2017 Nov 13, 2017	BUY	$14.8 - $18.06 $1.22 Million - $1.48 Million	82,099	82,099 $1.42 Million

Others Institutions Holding MRSN

# of Institutions

125

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

Eco R1 Capital, LLC San Francisco, CA

19.4M
Shares

$11.8 Million
1.59% of portfolio
Nextech Invest Ag

12.1M
Shares

$7.36 Million
3.72% of portfolio
Vr Adviser, LLC New York, NY

11.3M
Shares

$6.91 Million
2.22% of portfolio
Bain Capital Life Sciences Investors, LLC Boston, MA

8.66M
Shares

$5.28 Million
2.94% of portfolio
Black Rock Inc. New York, NY

8.38M
Shares

$5.11 Million
0.0% of portfolio

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $59.3M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account